Products - Synergy Biologics

Maximizing Outcomes, Minimizing Costs

surgiGRAFT™ Your Key to Tissue Reconstruction and Repair

Our advanced allograft technology delivers unparalleled soft tissue support and wound coverage, empowering surgeons to elevate the standard of care in diverse medical applications.

surgiGRAFT™ suite of products are amniotic tissue derived allografts intended for reconstruction, repair, or replacement of a donor recipients’ tissue. surgiGRAFT™ products serve to act as a tissue barrier/covering.

surgiGRAFT™ is regulated as human cells, tissue, or a cellular or tissue-based product (HCT/P) under 21 CFR part 1271 and section 361 of the Public Health Service (PHS) Act. Synergy Biologics, LLC is registered with the FDA as a tissue establishment.

Versatility

Allografts offer versatility in tissue reconstruction, repair, and replacement, catering to a wide range of medical needs across various specialties such as orthopedics, dermatology, and ophthalmology.

Reduced Morbidity

Compared to autografts (tissue taken from the patient's own body), allografts eliminate the need for additional surgical sites, reducing patient morbidity, post-operative pain, and recovery time, while still providing effective tissue support and regeneration.

Biocompatibility

Allografts are derived from human donors and processed to remove immunogenic components, making them biocompatible and reducing the risk of rejection, thereby promoting smoother integration and faster healing in patients.

Availability

Allografts provide a readily available source of tissue for patients, eliminating the need for additional procedures to harvest tissue from the patient's own body, thus streamlining treatment and ensuring timely access to essential care.

surgiGRAFT™

Allograft Benefits

Allografts offer a versatile, biocompatible solution for tissue reconstruction and repair, minimizing patient morbidity while maximizing healing outcomes through their adaptability and reduced risk of rejection.

Clinical Application - what content should be here?

surgiGRAFT™ Case Studies change to be indiv

PRODUCT INFORMATION

Amniotic tissue acts as an immune-privileged protective barrier during fetal development. Applied as an anatomical barrier, surgiGRAFT™ offers mechanical protection while providing a regenerative tissue matrix with specific anti-inflammatory, anti-scarring, and anti-microbial properties.

surgiGRAFT™ is an alternative to autologous skin grafting that eliminates the pain, co-morbidities, and procedure time associated with obtaining autologous grafts as well as an alternative to cost-prohibitive decellularized cadaveric skin or xenographic products.

Product Code	Description	Dimensions
SGD - 202	surgiGRAFTTM - Dry Graft	2 x 2 cm
SGD - 204	surgiGRAFTTM - Dry Graft	2 x 4 cm
SGD - 208	surgiGRAFTTM - Dry Graft	2 x 8 cm
SGD - 404	surgiGRAFTTM - Dry Graft	4 x 4 cm
SGD - 408	surgiGRAFTTM - Dry Graft	4 x 8 cm
SGD - 316	surgiGRAFTTM - Dry Graft	3 x 16 cm
SGD - 810	surgiGRAFTTM - Dry Graft	8 x 10 cm
SGD - 820	surgiGRAFTTM - Dry Graft	8 x 20 cm
SGD - 1016	surgiGRAFTTM - Dry Graft	10 x 16 cm